[1]
Manandhar, D. et al. 2022. Cystatin C as an Early Marker of Cardiorenal Syndrome Type 1 in Patients Admitted with Acute Heart Failure. Nepal Medical College Journal. 24, 4 (Dec. 2022), 316–320. DOI:https://doi.org/10.3126/nmcj.v24i4.50586.